MedTrace Logo

Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation

NCT06592365 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2024-09-19

No results posted yet for this study

Summary

This study was conducted to investigate the effects of green tea extracts on reducing blood glucose level

Conditions

  • Blood Sugar

Interventions

DIETARY_SUPPLEMENT

GTE

oral administration of GTE tablets once daily for 12 weeks

DIETARY_SUPPLEMENT

Placebo

oral administration of placebo tablets once daily for 12 weeks

Sponsors & Collaborators

  • Amorepacific Corporation

    lead INDUSTRY

Principal Investigators

  • Jae-Heon Kang, MD, PhD · Kangbuk Samsung Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-08
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06592365 on ClinicalTrials.gov